[Current location in website]

Links within the page

[Body starts here]
 

English Language Summary of Amendment to Extraordinary Report
(Rinjihokoku-sho no Teiseihoukoku-sho)
 
1. Reasons for Submission
  On May 12, 2006, Kirin Brewery Company, Limited (the "Company") submitted, pursuant to Article 24-5, Paragraph 4 of the Securities and Exchange Law of Japan (the "SEL") and Article 19, Paragraph 2, Section 7 of the Cabinet Office ordinance concerning disclosure of business enterprises' conditions and other matters, an extraordinary report (the "Extraordinary Report") to the Director General of the Kanto Local Finance Bureau of the Ministry of Finance Japan with respect to the approval by its Board of Directors of the implementation of a pure holding company system in July 2007. At the meeting of the Board of Directors held on February 7, 2007, the Board approved the relevant corporate split agreements (effective as of July 1, 2007) in connection with the implementation of the pure holding company system, and the Company made an announcement thereof on the same day. Accordingly, pursuant to Article 24-5, Paragraph 5 of the SEL, the Company would like to submit this amendment to the Extraordinary Report (the "Amendment").
2. Contents of Report
 
(A) Corporate Split implemented to transfer the Company's domestic alcoholic beverage business to Kirin Holdings Company, Limited ("Kirin Holdings")
  [Before this Amendment]
  5. Outline of Kirin Holdings after the Corporate Split
Amount of net assets and total assets were referenced as undetermined.
  [As amended by this Amendment]
  5. Outline of Kirin Holdings after the Corporate Split
    (5) Amount of net assets: 4,216 hundred million yen (as forecasted)
    (6) Amount of total assets: 5,749 hundred million yen (as forecasted)
(B) Corporate Split implemented to transfer the Company's pharmaceutical business to Kirin Pharma Company, Limited ("Kirin Pharma")
  [Before this Amendment]
  5. Outline of Kirin Holdings after the Corporate Split
Amount of net assets and total assets were referenced as undetermined.
  [As amended by this Amendment]
  5. Outline of Kirin Pharma after the Corporate Split
    (5) Amount of net assets: 650 hundred million yen (as forecasted)
    (6) Amount of total assets: 815 hundred million yen (as forecasted)
(C) Corporate Split implemented to transfer the Company's common support functions business (including personnel, accounting, administrative and procurement) to Kirin Business Expert Company, Limited ("Kirin Business Expert")
  [Before this Amendment]
  5. Outline of Kirin Business Expert after the Corporate Split
Amount of net assets and total assets were referenced as undetermined.
  [As amended by this Amendment]
  5. Outline of Kirin Business Expert after the Corporate Split
    (5) Amount of net assets: 9 hundred million yen (as forecasted)
    (6) Amount of total assets: 27 hundred million yen (as forecasted)


Return to Top